T1	Pharmacological_substance 1202 1213	simvastatin
T3	Disorder 1578 1581	IPF
T7	Pathway 1001 1019	Signaling pathways
T9	GGPs 185 189	CTGF
T11	GGPs 1463 1476	CTGF promoter
T12	Disorder 1328 1331	IPF
T16	Disorder 436 439	IPF
T20	GGPs 287 290;292 296	TGF beta
T21	Cellular_process 504 517	proliferation
T22	Pharmacological_substance 1983 1994	simvastatin
T23	Disorder 405 434	idiopathic pulmonary fibrosis
T27	GGPs 1778 1786	TGF-beta
T29	Anatomical_entity 1833 1837	lung
T30	Cell 1343 1354	fibroblasts
T31	GGPs 1670 1673	Ras
T33	Negative_regulation 952 962	inhibition
T36	GGPs 1176 1189	CTGF promoter
T38	GGPs 1053 1057	CTGF
T43	GGPs 152 183	Connective tissue growth factor
T45	GGPs 925 933	TGF-beta
T46	Cell 1838 1849	fibroblasts
T48	GGPs 60 91	transforming growth factor-beta
T49	Entity_Property 1547 1555	negative
T51	GGPs 1795 1808	CTGF promoter
T54	Cell 1590 1601	fibroblasts
T56	GGPs 2062 2066	CTGF
T60	Pharmacological_substance 1496 1507	simvastatin
T62	GGPs 1629 1641	small GTPase
T64	GGPs 1296 1304	TGF-beta
T65	Cell 690 701	fibroblasts
T67	GGPs 1137 1150	CTGF promoter
T68	Disorder 745 748	IPF
T70	Organic_compound_other 1432 1453	farnesylpyrophosphate
T71	Pharmacological_substance 829 840	Simvastatin
T72	Anatomical_entity 768 772	lung
T73	Gene_expression 32 42	expression
T74	GGPs 0 31	Connective tissue growth factor
T75	Pharmacological_substance 1028 1041	simvastatin's
T78	Pharmacological_substance 108 119	simvastatin
T80	GGPs 1058 1066	TGF-beta
T81	GGPs 856 860	CTGF
T82	Anatomical_entity 522 542	extracellular matrix
T83	Cell 896 912	fibroblast lines
T85	Negation_cue 1428 1431	not
T86	Anatomical_entity 2032 2036	lung
T87	Negative_regulation 1162 1172	Inhibition
T89	Gene_expression 870 888	protein expression
T91	GGPs 2099 2107	TGF-beta
T97	GGPs 1942 1946	RhoA
T98	Disorder 374 393	fibrogenic diseases
T99	Positive_regulation 47 56	induction
T103	Cell 773 784	fibroblasts
T107	GGPs 348 352	CTGF
T108	Positive_regulation 934 943	induction
T109	GGPs 259 285;292 296	transforming growth factor beta
T113	Anatomical_entity 684 689	renal
T114	Negative_regulation 1508 1518	inhibition
T115	Cell 2037 2048	fibroblasts
T116	Gene_expression 2067 2077	expression
T118	Pharmacological_substance 626 637	Simvastatin
E2	Pathway:T7 Participant:T38 Participant2:T80
E6	Cellular_process:T21 Theme:T88
E7	Negative_regulation:T33 Theme:E41
E9	Gene_expression:T73 Theme:T74
E10	Negative_regulation:T87 Cause:T1 Theme:T36 atLoc:T30
E11	Gene_expression:T89 Theme:T81 atLoc:T83
E14	Positive_regulation:T99 Cause:T48 Theme:T74
E16	Positive_regulation:T108 Cause:E7 Theme:T45
E17	Negative_regulation:T114 Cause:T60 Theme:T11
E18	Gene_expression:T116 Theme:T56
N3	Reference T1 UMLS:C0074554	Simvastatin
N12	Reference T3 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N32	Reference T9 UMLS:C0110610	connective tissue growth factor
N43	Reference T12 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N60	Reference T16 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N77	Reference E6 UMLS:C1326347	fibroblast proliferation
N81	Reference T22 UMLS:C0074554	Simvastatin
N82	Reference T23 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N98	Reference T27 UMLS:C0040690	Transforming Growth Factor beta
N110	Reference T29 UMLS:C0024109	Lung
N112	Reference T30 UMLS:C0016030	Fibroblasts
N146	Reference T38 UMLS:C0110610	connective tissue growth factor
N167	Reference T43 UMLS:C0110610	connective tissue growth factor
N179	Reference T46 UMLS:C0016030	Fibroblasts
N188	Reference T49 UMLS:C0205160	Negative
N209	Reference T54 UMLS:C0016030	Fibroblasts
N222	Reference T56 UMLS:C0110610	connective tissue growth factor
N234	Reference T60 UMLS:C0074554	Simvastatin
N247	Reference T64 UMLS:C0040690	Transforming Growth Factor beta
N249	Reference T65 UMLS:C0016030	Fibroblasts
N260	Reference T68 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N265	Reference T70 UMLS:C0060069	farnesyl pyrophosphate
N268	Reference T71 UMLS:C0074554	Simvastatin
N272	Reference T72 UMLS:C0024109	Lung
N279	Reference T74 UMLS:C0110610	connective tissue growth factor
N284	Reference T75 UMLS:C0074554	Simvastatin
N296	Reference T78 UMLS:C0074554	Simvastatin
N304	Reference T80 UMLS:C0040690	Transforming Growth Factor beta
N307	Reference T82 UMLS:C0015350	Extracellular Matrix
N313	Reference T85 UMLS:C1518422	Negation
N318	Reference T86 UMLS:C0024109	Lung
N346	Reference T91 UMLS:C0040690	Transforming Growth Factor beta
N372	Reference T97 UMLS:C0084340	rhoA GTP-Binding Protein
N389	Reference T103 UMLS:C0016030	Fibroblasts
N403	Reference T107 UMLS:C0110610	connective tissue growth factor
N424	Reference T113 UMLS:C0022646	Kidney
N432	Reference T115 UMLS:C0016030	Fibroblasts
N441	Reference T118 UMLS:C0074554	Simvastatin
T110	GGPs 126 129	Rho
T120	Negative_regulation 95 104	abrogated
E21	Negative_regulation:T120 Cause:T78 Theme:E14
E22	Negative_regulation:T120 Cause:T78 Theme:E9
T121	Biological_process 306 318	fibrogenesis
E25	Biological_process:T121 
T32	Positive_regulation 300 305	drive
E26	Positive_regulation:T32 Theme:E25 Cause:T9
R4	member_of Arg1:T23 Arg2:T98	
T19	Positive_regulation 332 344	upregulation
E13	Positive_regulation:T19 Theme:T107 disorder:T23
T88	Cell 493 503	fibroblast
E28	Positive_regulation:T24 Cause:E13 Theme:E15
T96	Localization 543 553	deposition
E29	Localization:T96 Theme:T82
T124	Biological_process 660 680	antifibrotic actions
E34	Biological_process:T124 Cause:T118 Theme:T65
T66	Subject 761 767	normal
T94	Negative_regulation 841 848	reduces
E38	Negative_regulation:T94 Cause:T71 Theme:E39
T8	Gene_expression 861 865;878 888	gene expression
E39	Gene_expression:T8 Theme:T81 atLoc:T83
N4	Reference E11 UMLS:C1519614	Genetic Translation Process
N6	Reference E39 UMLS:C0040649	Transcription, Genetic
E40	Negative_regulation:T94 Cause:T71 Theme:E11
T13	Organic_compound_other 970 981	cholesterol
T52	Molecular_function 982 991	synthesis
E19	Molecular_function:T52 Product:T13
T117	Pathway 970 999	cholesterol synthesis pathway
E41	Pathway:T117 
N7	Reference E41 UMLS:C1156542	Sterol Biosynthesis Pathway
N8	Reference T13 UMLS:C0008377	Cholesterol
T44	Negative_regulation 914 924	overriding
E4	Negative_regulation:T44 Cause:T71 Theme:E16
R5	part_of Arg1:T65 Arg2:T113	
R6	part_of Arg1:T103 Arg2:T72	
N9	Reference T81 UMLS:C0110610	connective tissue growth factor
A3	Organism_sbjct T66 Human
T102	Subject 739 744	human
R7	Subject_Disorder Arg1:T102 Arg2:T68	
T84	Cell 773 784	fibroblasts
T125	Anatomical_entity 768 772	lung
R8	part_of Arg1:T84 Arg2:T125	
R9	part_of Arg1:T125 Arg2:T66	
R10	part_of Arg1:T72 Arg2:T102	
T126	Positive_regulation 1020 1027	driving
E42	Positive_regulation:T126 Cause:T75 Theme:E2
T17	Regulation 1042 1049	effects
E44	Regulation:T17 Cause:E2 Theme:E54
T6	Positive_regulation 1305 1315	stimulated
E45	Positive_regulation:T6 Cause:T64 Theme:T35
T34	Subject 1328 1331	IPF
R11	Subject_Disorder Arg1:T34 Arg2:T12	
T35	Cell 1343 1354	fibroblasts
T53	Subject 1336 1342	normal
A4	Organism_sbjct T53 Human
A5	Patient_sbjct T53 Control
A6	Organism_sbjct T34 Human
A7	Patient_sbjct T34 Patient
R12	part_of Arg1:T35 Arg2:T53	
R13	part_of Arg1:T30 Arg2:T34	
E12	Positive_regulation:T6 Cause:T64 Theme:T30
E46	Negative_regulation:T87 Theme:T36 Cause:T1 atLoc:T35
T5	Subject 1578 1581	IPF
R14	Subject_Disorder Arg1:T5 Arg2:T3	
T55	Organic_compound_other 1388 1415	geranylgeranylpyrophosphate
T59	Organic_compound_other 1417 1421	GGPP
T92	Positive_regulation 1455 1462	induces
E47	Positive_regulation:T92 Cause:T55 Theme:T11 atLoc:T100
E48	Positive_regulation:T92 Theme:T11 Cause:T70 Cue2:T85
A11	Negated E48
T15	Organic_compound_other 1542 1546	GGPP
T100	Cell 1568 1573	IMR90
T101	GGPs 1642 1645	Rho
R16	member_of Arg1:T101 Arg2:T62	
T104	Correlation 1646 1657	involvement
E50	Correlation:T104 Theme:E47 Theme2:T101
R17	part_of Arg1:T54 Arg2:T5	
T58	GGPs 1713 1716	Rho
T112	GGPs 1727 1738	C3 exotoxin
T128	Negative_regulation 1717 1726	inhibitor
E51	Negative_regulation:T128 Theme:T58 Cause:T112
T129	Negative_regulation 1767 1777	suppressed
E52	Negative_regulation:T129 Theme:T51 Cause:T112 atLoc:T46
T130	Positive_regulation 1787 1794	induced
E53	Positive_regulation:T130 Cause:T27 Theme:T51
R19	part_of Arg1:T46 Arg2:T29	
T42	GGPs 2005 2008	Rho
R20	part_of Arg1:T115 Arg2:T86	
E55	Positive_regulation:T39 Theme:E18 Cause:T22
N14	Reference E18 UMLS:C0017262	Gene Expression
T61	Pathway 2082 2093	interaction
E56	Pathway:T61 Participant:T91 Participant2:T56
E57	Positive_regulation:T39 Theme:E56 Cause:T22
N1	Reference T48 UMLS:C0040690	Transforming Growth Factor beta
N16	Reference T109 UMLS:C0040690	Transforming Growth Factor beta
N17	Reference T20 UMLS:C0040690	Transforming Growth Factor beta
N18	Reference T45 UMLS:C0040690	Transforming Growth Factor beta
N19	Reference E9 UMLS:C0017262	Gene Expression
N2	Reference T110 UMLS:C0174045	rho GTP-Binding Proteins
N20	Reference T101 UMLS:C0174045	rho GTP-Binding Proteins
N21	Reference T42 UMLS:C0174045	rho GTP-Binding Proteins
N22	Reference T67 UMLS:C0086860	promoter
N23	Reference T36 UMLS:C0086860	promoter
N25	Reference T11 UMLS:C0086860	promoter
N26	Reference T51 UMLS:C0086860	promoter
N27	Reference T31 UMLS:C0242853	ras Proteins
N28	Reference T62 UMLS:C0751984	Monomeric GTP-Binding Proteins
N29	Reference T58 UMLS:C0174045	rho GTP-Binding Proteins
N30	Reference T88 UMLS:C0016030	Fibroblasts
N31	Reference T35 UMLS:C0016030	Fibroblasts
N33	Reference T125 UMLS:C0024109	Lung
N34	Reference T55 UMLS:C0061230	geranylgeranyl pyrophosphate
N35	Reference T59 UMLS:C0061230	geranylgeranyl pyrophosphate
N37	Reference T15 UMLS:C0061230	geranylgeranyl pyrophosphate
N38	Reference T112 UMLS:C0059949	exoenzyme C3, Clostridium botulinum
N39	Reference T100 UMLS:C0682523	human cell line
A19	Organism_sbjct T102 Human
A20	Patient_sbjct T102 Patient
A21	Organism_sbjct T5 Human
A22	Patient_sbjct T5 Patient
N50	Reference E25 UMLS:C0596570	fibrogenesis
N54	Reference T98 UMLS:C0016059	Fibrosis
T24	Positive_regulation 456 467	responsible
N74	Reference E44 UMLS:C1327622	Regulation of biological process
R18	member_of Arg1:T31 Arg2:T62	
E1	Positive_regulation:T92 Cause:T55 Theme:T11 atLoc:T54
T14	Biological_process 605 624	fibrogeneic  events
E3	Biological_process:T14 
N79	Reference E3 UMLS:C0596570	fibrogenesis
T25	Artificial_process 572 579	therapy
E5	Artificial_process:T25 Theme:E3 Cue:T37
T37	Negation_cue 559 561	no
A27	Negated E5
T26	Correlation 472 482	associated
E15	Correlation:T26 Theme:E6 Theme2:E29
N48	Reference E15 UMLS:C0332281	Associated with
E30	Biological_process:T124 Cause:T118 Theme:T103
E31	Biological_process:T124 Cause:T118 Theme:T84
T63	Negative_regulation 1255 1272	reducing activity
E33	Negative_regulation:T63 atLoc:T35 Cause:T1 Theme:T36
E35	Negative_regulation:T63 atLoc:T30 Cause:T1 Theme:T36
T76	Artificial_process 1821 1832	transfected
E36	Artificial_process:T76 Theme:T46
N80	Reference E36 UMLS:C0040669	Transfection
N83	Reference T83 UMLS:C0682524	fibroblast cell line
N24	Reference E2 UMLS:C0037080	Signal Pathways
T77	Pathway 126 149	Rho signaling mechanism
E37	Pathway:T77 Participant:T110 Participant2:T78
N84	Reference E37 UMLS:C1514941	Rho Cell Motility Signaling Pathway
T79	Pathway 2005 2028	Rho signaling mechanism
E49	Pathway:T79 Participant:T42 atLoc:T115
N85	Reference E49 UMLS:C1514941	Rho Cell Motility Signaling Pathway
T90	Pathway 1067 1078	interaction
E54	Pathway:T90 Participant:T80 Participant2:T38
T4	GGPs 201 221	profibrotic mediator
R21	member_of Arg1:T9 Arg2:T4	
T28	Correlation 223 227	acts
E8	Correlation:T28 Theme:T9 Theme2:T20
N5	Reference E8 UMLS:C0332281	Associated with
N41	Reference E14 UMLS:C1879547	Activation action
N42	Reference E22 UMLS:C3463820	Inhibition
N44	Reference E21 UMLS:C3463820	Inhibition
N45	Reference E26 UMLS:C1879547	Activation action
N46	Reference E13 UMLS:C1879547	Activation action
N47	Reference E28 UMLS:C1879547	Activation action
N49	Reference E5 UMLS:C0087111	Therapeutic procedure
N53	Reference E38 UMLS:C3463820	Inhibition
N56	Reference E40 UMLS:C3463820	Inhibition
N57	Reference E4 UMLS:C3463820	Inhibition
N58	Reference E7 UMLS:C3463820	Inhibition
N59	Reference E10 UMLS:C3463820	Inhibition
N61	Reference E46 UMLS:C3463820	Inhibition
N55	Reference E35 UMLS:C3463820	Inhibition
N52	Reference E33 UMLS:C3463820	Inhibition
N62	Reference E17 UMLS:C3463820	Inhibition
N63	Reference E51 UMLS:C3463820	Inhibition
N64	Reference E52 UMLS:C3463820	Inhibition
N10	Reference E53 UMLS:C1879547	Activation action
N65	Reference E47 UMLS:C1879547	Activation action
N36	Reference E1 UMLS:C1879547	Activation action
N66	Reference E48 UMLS:C1879547	Activation action
N67	Reference E12 UMLS:C1879547	Activation action
N68	Reference E45 UMLS:C1879547	Activation action
N69	Reference E42 UMLS:C1879547	Activation action
N70	Reference E16 UMLS:C1879547	Activation action
T39	Positive_regulation 2053 2061	modulate
N71	Reference E57 UMLS:C1879547	Activation action
N13	Reference E55 UMLS:C1879547	Activation action
N72	Reference E50 UMLS:C0332281	Associated with
R1	member_of Arg1:T43 Arg2:T4	
N73	Reference E29 UMLS:C1744691	establishment and maintenance of localization
N51	Reference E54 UMLS:C0037080	Signal Pathways
N15	Reference E56 UMLS:C0037080	Signal Pathways
N75	Reference T102 UMLS:C0030705	Patients
N11	Reference T66 UMLS:C2986479	Healthy Control
N76	Reference T34 UMLS:C0030705	Patients
N40	Reference T53 UMLS:C2986479	Healthy Control
N78	Reference T5 UMLS:C0030705	Patients
N86	Reference T37 UMLS:C1518422	Negation
